
February 8, 2007 Prescription Drug Imports up 34% in January 2007 Boca Raton, Fla - CANAMERICA DRUGS today announced to its stockholders that its sales are up 34% for January 2007. One month into year two of the Medicare Part D pharmaceutical drug program, private drug imports are on the rise across the USA. Reasons cited are the increased premiums, reduced formularies, and bigger doughnut hole in the 2007 Medicare Part D plans. Also cited is the increasing number of younger American consumers meeting their prescription needs through mail order. While importation has long been popular with American seniors, a growing number of Americans of all ages obtain their medications from foreign locations, often seeking out suppliers in Canada like Canamerica Drugs.com, a specially licensed and regulated IPS (International Pharmacy Service) pharmacy. More and more people have come to know that medications from Canada are safe and reliable. Health Canada ensures the safety of medicines purchased from licensed sources, using strict guidelines similar to those of the FDA. CanAmerica Drugs has been inspected by both Health Canada and the Manitoba Pharmaceutical Association (MPhA), and is IPS licensed to provide international pharmaceutical services by mail. Of the all pharmacies in Canada, only 20 pharmacies have the special designation of an IPS license in 2007. "It's true that many of our member consumers are using us as a supplement or replacement for Part D, but a growing number are younger Americans seeking affordable medications. You don't have to be a Senior to want to save money." said Jeremy Charney, President of CanAmerica Drugs.com. Recently bi-partisan legislation has been re-introduced in both houses of Congress, aimed at easing importation of FDA approved medications from Canada and other countries. (The Pharmaceutical Market Access and Drug Safety Act - S. 242/H.R. 380) This bill will permit Americans to purchase prescription medications by mail from registered Canadian pharmacies like CanAmerica Drugs.com, for personal use and may eventually allow licensed U.S. pharmacies and wholesalers to import wholesale medications from several designated countries in bulk. It also requires FDA inspections of Canadian pharmacies and their supply systems. CanAmerica Drugs.com strongly endorses the first provision of the bill, and welcomes the prospect of FDA inspection. "We feel that anything that increases our members' security and helps them get their medications more easily can only be good." Charney said. However, he cautions: "It is unlikely that the savings from a Canadian supply would make it to the consumer through bulk importation: Any savings would most likely be absorbed by the wholesalers & retailers, increasing their profit. It's also unlikely that the manufacturers would provide quantities sufficient for the Canadian supply system to supply bulk medications to the U.S. market for any length of time." "In any case, you're better off purchasing directly: You can be certain of the savings and reliability of supply."
|